We are live on ! Find out more
AL

Aspiriant LLC Portfolio holdings

AUM $4.05B
1-Year Est. Return 19.01%
This Fund
S&P 500
This Quarter Est. Return
-1.34%
1 Year Est. Return
+19.01%
3 Year Est. Return
+47.13%
5 Year Est. Return
+48.95%
10 Year Est. Return
+147.53%
AUM
$2.77B
AUM Growth
+$134M
Cap. Flow
+$184M
Cap. Flow %
6.65%
Top 10 Hldgs %
66.52%
Holding
311
New
19
Increased
124
Reduced
101
Closed
23

Sector Composition

Rank Sector Weight
1 Technology 4.54%
2 Financials 2.48%
3 Communication Services 1.28%
4 Consumer Discretionary 0.73%
5 Healthcare 0.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDY icon
101
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.8B
$1.83M 0.07%
3,221
VNQI icon
102
Vanguard Global ex-US Real Estate ETF
VNQI
$3.53B
$1.79M 0.06%
45,346
-498
-1% -$21.6K
DIS icon
103
Walt Disney
DIS
$172B
$1.77M 0.06%
15,905
+92
+0.6% +$9.66K
VUSB icon
104
Vanguard Ultra-Short Bond ETF
VUSB
$8.93B
$1.75M 0.06%
35,190
+228
+0.7% +$11.3K
SCHB icon
105
Schwab US Broad Market ETF
SCHB
$42.9B
$1.69M 0.06%
74,244
-3,909
-5% -$89.3K
LOW icon
106
Lowe's Companies
LOW
$122B
$1.62M 0.06%
6,579
-68
-1% -$18.2K
MA icon
107
Mastercard
MA
$496B
$1.6M 0.06%
3,045
+160
+6% +$82.8K
BAC icon
108
Bank of America
BAC
$438B
$1.59M 0.06%
36,278
+1,588
+5% +$69.9K
PAYX icon
109
Paychex
PAYX
$42.3B
$1.58M 0.06%
11,294
-385
-3% -$54.7K
IWP icon
110
iShares Russell Mid-Cap Growth ETF
IWP
$19.7B
$1.56M 0.06%
12,313
ABBV icon
111
AbbVie
ABBV
$469B
$1.56M 0.06%
8,777
+412
+5% +$75.7K
WFC icon
112
Wells Fargo
WFC
$263B
$1.55M 0.06%
22,051
-2,379
-10% -$162K
AXP icon
113
American Express
AXP
$227B
$1.53M 0.06%
5,172
+170
+3% +$48.8K
VBK icon
114
Vanguard Small-Cap Growth ETF
VBK
$23.2B
$1.53M 0.06%
5,448
+26
+0.5% +$7.35K
VYM icon
115
Vanguard High Dividend Yield ETF
VYM
$81.9B
$1.52M 0.05%
11,910
+1,594
+15% +$208K
MRK icon
116
Merck
MRK
$325B
$1.52M 0.05%
15,272
-105
-0.7% -$10.8K
DSI icon
117
iShares MSCI KLD 400 Social ETF
DSI
$5.18B
$1.49M 0.05%
13,494
+7,256
+116% +$811K
V icon
118
Visa
V
$701B
$1.48M 0.05%
4,698
-698
-13% -$210K
WMT icon
119
Walmart Inc
WMT
$903B
$1.48M 0.05%
16,409
+1,959
+14% +$170K
NFLX icon
120
Netflix
NFLX
$305B
$1.4M 0.05%
15,730
+1,740
+12% +$143K
SCHM icon
121
Schwab US Mid-Cap ETF
SCHM
$14.5B
$1.38M 0.05%
49,695
+2,448
+5% +$69.8K
SCHV
122
Schwab US Large-Cap Value ETF
SCHV
$15.8B
$1.37M 0.05%
52,559
+7,460
+17% +$201K
SCHD icon
123
Schwab US Dividend Equity ETF
SCHD
$104B
$1.37M 0.05%
49,991
+4,304
+9% +$122K
EEMV icon
124
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.41B
$1.32M 0.05%
22,684
-1,851
-8% -$112K
IUSB icon
125
iShares Core Universal USD Bond ETF
IUSB
$43.1B
$1.31M 0.05%
29,048
+11,218
+63% +$515K

Similar funds

Aspiriant LLC's Q4 2024 Portfolio in Review

As of Q4 2024, Aspiriant LLC held 311 positions worth $2.77B, up 5.1% from $2.64B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Aspiriant LLC deployed $184M of net new capital in Q4 2024, opening 19 new positions and adding to 124 existing holdings. Its largest new stake was iShares ESG Optimized MSCI USA ETF: 6,868 shares worth $835K.

By sector, the portfolio is most concentrated in Technology at 4.5% of assets, up from 4.5% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Vanguard Dividend Appreciation ETF, an estimated $3.46M trimmed.

  • Aspiriant LLC's largest Q4 2024 buy was iShares ESG Optimized MSCI USA ETF: 6,868 shares worth $835K.
  • Aspiriant LLC added most to Vanguard Small-Cap Value ETF in Q4 2024, an estimated $74.5M increase.
  • Aspiriant LLC's biggest Q4 2024 reduction was Vanguard Dividend Appreciation ETF, cutting an estimated $3.46M.
  • Aspiriant LLC fully exited Robinhood in Q4 2024, selling an estimated $985K.
  • Aspiriant LLC's ten largest holdings make up 67% of its $2.77B portfolio in Q4 2024.
  • Aspiriant LLC opened 19 new positions and closed 23 in Q4 2024.
  • Aspiriant LLC's portfolio value rose 5.1% quarter-over-quarter to $2.77B.

Based on Aspiriant LLC's 13F filing for Q4 2024, filed 16 Jan 2025.